Large-scale candoxatril asymmetric hydrogenation

被引：23

作者：

Bulliard, M ^{[1
]}

Laboue, B ^{[1
]}

Lastennet, J ^{[1
]}

Roussiasse, S ^{[1
]}

机构：

[1] PPG SIPSY, ZI Croix Cadeau, F-49242 Avrille, France

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2001年 / 5卷 / 04期

关键词：

D O I：

10.1021/op010005w

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

Ruthenium-catalyzed asymmetric hydrogenation was used to prepare tons of a key chiral succinate intermediate for clinical trials quantities of candoxatril. MeOBiphep was used as the ligand, and the catalyst was generated in situ from RuCOD-Bismethylallyl. THF was the best cosolvent for the reaction leading to a selective hydrogenation and a process which was readily amenable on large scale.

引用

页码：438 / 441

页数：4

共 8 条

[1] ASYMMETRIC-SYNTHESIS BY METAL BINAP CATALYSTS
AKUTAGAWA, S
[J]. APPLIED CATALYSIS A-GENERAL, 1995, 128 (02) : 171 - 207
[2] DINUCLEAR RUTHENIUM(II) CARBOXYLATE COMPLEXES
ALBERS, MO
SINGLETON, E
YATES, JE
MCCORMICK, FB
[J]. INORGANIC SYNTHESES, 1989, 26 : 249 - 258
[3] Me-DuPHOS-Rh-catalyzed asymmetric synthesis of the pivotal glutarate intermediate for candoxatril
Burk, MJ
Bienewald, F
Challenger, S
Derrick, A
Ramsden, JA
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (09) : 3290 - 3298
[4] CEREGHETTI M, 1990, Patent No. 398132
[5] Stereoselective synthesis of a candoxatril intermediate via asymmetric hydrogenation
Challenger, S
Derrick, A
Mason, CP
Silk, TV
[J]. TETRAHEDRON LETTERS, 1999, 40 (11) : 2187 - 2190
[6] CHALLENGER S, 1995, Patent No. 644176
[7] DANILEWICZ JC, 1989, Patent No. 342850
[8] ENANTIOSELECTIVE HYDROGENATION REACTIONS WITH A FULL SET OF PREFORMED AND PREPARED IN-SITU CHIRAL DIPHOSPHINE-RUTHENIUM(II) CATALYSTS
GENET, JP
PINEL, C
RATOVELOMANANAVIDAL, V
MALLART, S
PFISTER, X
BISCHOFF, L
DEANDRADE, MCC
DARSES, S
GALOPIN, C
LAFFITTE, JA
[J]. TETRAHEDRON-ASYMMETRY, 1994, 5 (04) : 675 - 690

← 1 →